Total Payments
$2,421
2024 Payments
$146.46
Companies
24
Transactions
93
Medicare Patients
7,762
Medicare Billing
$634,924
Payment Breakdown by Category
Food & Beverage$2,406 (99.4%)
Education$14.90 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,406 | 92 | 99.4% |
| Education | $14.90 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $356.34 | 4 | $0 (2018) |
| Amgen Inc. | $344.72 | 16 | $0 (2023) |
| Boston Scientific Corporation | $284.00 | 4 | $0 (2024) |
| Novo Nordisk Inc | $247.98 | 13 | $0 (2020) |
| Allergan Inc. | $150.15 | 3 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $134.88 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $133.97 | 9 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $116.77 | 6 | $0 (2018) |
| Gilead Sciences, Inc. | $114.43 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.54 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.46 | 2 | Boston Scientific Corporation ($146.46) |
| 2023 | $134.98 | 2 | Amgen Inc. ($134.98) |
| 2022 | $81.91 | 5 | Kowa Pharmaceuticals America, Inc. ($47.48) |
| 2021 | $149.96 | 4 | Gilead Sciences, Inc. ($100.00) |
| 2020 | $19.10 | 1 | Novo Nordisk Inc ($19.10) |
| 2019 | $355.28 | 16 | Allergan Inc. ($131.79) |
| 2018 | $733.36 | 20 | Merck Sharp & Dohme Corporation ($258.37) |
| 2017 | $800.27 | 43 | Novo Nordisk Inc ($157.21) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $130.07 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/31/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Cardiology | ||||||
| 05/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 06/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: DIABETES | ||||||
| 06/01/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Cardiovascular | ||||||
| 05/03/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Cardiovascular | ||||||
| 02/10/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiovascular | ||||||
| 10/12/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: Cardiovascular | ||||||
| 06/15/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 03/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiology | ||||||
| 02/25/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.55 | General |
| Category: Cardiovascular | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
| 11/20/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Allergy/Immunology | ||||||
| 11/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes | ||||||
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DIABETES | ||||||
| 10/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 09/10/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Cardiovascular | ||||||
| 08/05/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.46 | General |
| Category: Cardiovascular | ||||||
| 07/10/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 07/03/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2019 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $129.91 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,109 | 3,033 | $929,370 | $183,936 |
| 2022 | 13 | 1,970 | 2,967 | $870,610 | $172,361 |
| 2021 | 12 | 1,930 | 2,842 | $842,744 | $162,760 |
| 2020 | 13 | 1,753 | 2,290 | $625,514 | $115,867 |
Total Patients
7,762
Total Services
11,132
Medicare Billing
$634,924
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 332 | 608 | $373,920 | $65,228 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 516 | $216,720 | $38,773 | 17.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 224 | 224 | $143,808 | $34,122 | 23.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 32 | 32 | $19,776 | $9,023 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 54 | $53,838 | $7,534 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 496 | 867 | $18,016 | $7,225 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 77 | $13,552 | $5,528 | 40.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 70 | 70 | $11,760 | $5,307 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 150 | 150 | $16,200 | $5,264 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 361 | 400 | $58,000 | $4,704 | 8.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $3,780 | $1,228 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 495 | $304,425 | $52,912 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 280 | 605 | $254,100 | $48,310 | 19.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 211 | 211 | $135,462 | $32,953 | 24.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 31 | 31 | $19,158 | $8,157 | 42.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 90 | 90 | $15,840 | $6,169 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 148 | 149 | $16,092 | $5,152 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $36,889 | $4,806 | 13.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 336 | 383 | $55,535 | $4,509 | 8.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 55 | 55 | $7,975 | $3,852 | 48.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 445 | 824 | $16,480 | $2,432 | 14.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $4,494 | $1,850 | 41.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 35 | 35 | $3,780 | $1,215 | 32.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 38 | $380.00 | $44.04 | 11.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 304 | 585 | $359,775 | $66,341 | 18.4% |
About Dr. Patrick Cavanaugh, MD
Dr. Patrick Cavanaugh, MD is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699736983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Cavanaugh, MD has received a total of $2,421 in payments from pharmaceutical and medical device companies, with $146.46 received in 2024. These payments were reported across 93 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,406).
As a Medicare-enrolled provider, Cavanaugh has provided services to 7,762 Medicare beneficiaries, totaling 11,132 services with total Medicare billing of $634,924. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 03/28/2006
- Last Updated 03/02/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699736983
Products in Payments
- Repatha (Biological) $175.39
- Victoza (Drug) $157.21
- LINZESS (Drug) $155.12
- WATCHMAN FLX (Device) $146.46
- Corlanor (Drug) $138.36
- WATCHMAN (Device) $137.54
- Livalo (Drug) $133.97
- VIBERZI (Drug) $129.91
- GARDASIL (Biological) $122.52
- PNEUMOVAX 23 (Biological) $122.52
- PRALUENT (Drug) $116.77
- ZOSTAVAX (Biological) $97.97
- Ozempic (Drug) $90.77
- JARDIANCE (Drug) $61.55
- FARXIGA (Drug) $53.18
- ENTRESTO (Drug) $42.93
- ELIQUIS (Drug) $38.19
- FLUZONE HIGH-DOSE (Drug) $37.48
- PRALUENT ALIROCUMAB INJECTION (Biological) $37.45
- UCERIS (Drug) $31.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163